Co-Crystal of Rosiglitazone With Berberine Ameliorates Hyperglycemia and Insulin Resistance Through the PI3K/AKT/TXNIP Pathway In Vivo and In Vitro

• Main Authors: Qichen He (Author), Bo Chen (Author), Gang Wang (Author), Duanfang Zhou (Author), Hongfang Zeng (Author), Xiaoli Li (Author), Yi Song (Author), Xiaoping Yu (Author), Wenxin Liang (Author), Huiling Chen (Author), Xu Liu (Author), Qiuya Wu (Author), Lihong Wu (Author), Limei Zhang (Author), Huizhen Li (Author), Xiangnan Hu (Author), Weiying Zhou (Author)
• Format: Book
• Published: Frontiers Media S.A., 2022-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Type 2 diabetes mellitus (T2DM) is a chronic metabolic disease characterized by insulin resistance and hyperglycemia. This study examined the effect and elucidated the mechanism of improvement of hyperglycemia and insulin resistance by a co-crystal of rosiglitazone with berberine (RB) in...